Literature DB >> 18428664

Locomotor behavior.

R Christopher Pierce1, Peter W Kalivas.   

Abstract

The study of locomotor activation in rodents does not involve extensive learning or conditioning, and so this dependent measure is often used as the initial screen for pharmacological effects predictive of therapeutic efficacy of a drug class in humans. Methods for evaluating locomotor behavior in rodents fall into two general categories: automated monitoring of behavior and direct observational techniques. This unit presents protocols for measurement of locomotor activity using photocell-based automated monitoring systems, and direct observation using interval and ordinal scales. Other methods used to quantify locomotor activity include video-based systems, rotometers, and running wheels; these are discussed in the commentary. The protocols provided are designed for rats, although they can easily be adapted for use with mice and other rodents. Copyright by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 18428664     DOI: 10.1002/0471142301.ns0801s40

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  13 in total

1.  AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.

Authors:  Mark D Black; Rachel J Stevens; Nancy Rogacki; Robert E Featherstone; Yaw Senyah; Odessa Giardino; Beth Borowsky; Jeanne Stemmelin; Caroline Cohen; Philippe Pichat; Michal Arad; Segev Barak; Amaya De Levie; Ina Weiner; Guy Griebel; Geoffrey B Varty
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

2.  Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2017-07-20       Impact factor: 2.643

3.  Repeated intravenous cocaine experience: development and escalation of pre-drug anticipatory 50-kHz ultrasonic vocalizations in rats.

Authors:  Sean T Ma; Esther Y Maier; Allison M Ahrens; Timothy Schallert; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2010-04-09       Impact factor: 3.332

4.  Genetic absence of nNOS worsens fetal alcohol effects in mice. I: behavioral deficits.

Authors:  Bahri Karacay; Nancy E Bonthius; Jeffrey Plume; Daniel J Bonthius
Journal:  Alcohol Clin Exp Res       Date:  2015-02       Impact factor: 3.455

5.  Assessment of ultrasonic vocalizations during drug self-administration in rats.

Authors:  Esther Y Maier; Sean T Ma; Allison Ahrens; Timothy J Schallert; Christine L Duvauchelle
Journal:  J Vis Exp       Date:  2010-07-22       Impact factor: 1.355

6.  D1 and D2 specific dopamine antagonist modulate the caudate nucleus neuronal responses to chronic methylphenidate exposure.

Authors:  Sidish Venkataraman; Catherine Claussen; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2016-11-16       Impact factor: 3.575

7.  Caudate neuronal recording in freely behaving animals following acute and chronic dose response methylphenidate exposure.

Authors:  Catherine M Claussen; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2015-06-20       Impact factor: 3.533

8.  Environmental novelty causes stress-like adaptations at nucleus accumbens synapses: implications for studying addiction-related plasticity.

Authors:  Patrick E Rothwell; Saïd Kourrich; Mark J Thomas
Journal:  Neuropharmacology       Date:  2011-02-16       Impact factor: 5.250

9.  Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.

Authors:  Maria Elena Reveron; Esther Y Maier; Christine L Duvauchelle
Journal:  Behav Brain Res       Date:  2009-11-03       Impact factor: 3.332

10.  Opposing regulation of dopaminergic activity and exploratory motor behavior by forebrain and brainstem cholinergic circuits.

Authors:  Jyoti C Patel; Elsa Rossignol; Margaret E Rice; Robert P Machold
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.